ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$294.98
Tradestie Score
48
Market Cap
$431.71B
P/E Ratio
50.5
Revenue Growth
0.1%
Analyst Upside
+5.3%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1437.29
|
$739.95B | 45.8 | 27 | Compare |
|
JNJ
Johnson & Johnson
|
$280.41
|
$448.07B | 42.6 | 45 | Compare |
|
NVO
Novo-Nordisk A/S
|
$41.09
|
$262.92B | 10.3 | 39 | Compare |
|
AZN
AstraZeneca PLC
|
$185.48
|
$261.56B | 26.4 | 35 | Compare |
|
NVS
Novartis AG
|
$160.32
|
$254.99B | 31.2 | 41 | Compare |
|
ABT
Abbott Laboratories
|
$109.29
|
$232.30B | 41.2 | 38 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.18
|
$225.13B | 149.5 | 50 | Compare |
|
AMGN
Amgen Inc
|
$468.11
|
$160.70B | 27.0 | 41 | Compare |
|
PFE
Pfizer Inc.
|
$29.45
|
$154.70B | 41.9 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$169.73
|
$137.92B | - | 37 | Compare |
More ABBV Analysis
Data updated: Nov 11, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry